Advanced search
Publication Cover
Hematology Volume 26, 2021 - Issue 1
Submit an article Journal homepage
2,494
Views
2
CrossRef citations to date
0
Altmetric
Articles

2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests

Ye Zhoua Department of Blood Transfusion, Changzheng Hospital, Naval Medical University, Shanghai, People’s Republic of ChinaView further author information
,
Leiyu Chena Department of Blood Transfusion, Changzheng Hospital, Naval Medical University, Shanghai, People’s Republic of ChinaView further author information
,
Tianshu Jianga Department of Blood Transfusion, Changzheng Hospital, Naval Medical University, Shanghai, People’s Republic of ChinaView further author information
,
Liangfeng Fanb Blood Group Reference Laboratory, Shanghai Blood Center, Shanghai, People’s Republic of ChinaView further author information
,
Hang Leic Department of Blood Transfusion, Laboratory Diagnosis Center, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaView further author information
,
Yuqing Wangc Department of Blood Transfusion, Laboratory Diagnosis Center, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaView further author information
,
Hasiyati Heililahongc Department of Blood Transfusion, Laboratory Diagnosis Center, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaView further author information
,
Jianqing Mid Department of Hematology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaView further author information
,
Danxin Due Department of Blood Transfusion, Huashan Hospital Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Tianhong Miaof Blood Group Reference Laboratory, Beijing Red Cross Blood Center, Beijing, People’s Republic of ChinaView further author information
,
Rong Xiae Department of Blood Transfusion, Huashan Hospital Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Xuefeng Wangc Department of Blood Transfusion, Laboratory Diagnosis Center, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaView further author information
,
Dong Xiangb Blood Group Reference Laboratory, Shanghai Blood Center, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
,
Xiaohong Caic Department of Blood Transfusion, Laboratory Diagnosis Center, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-3999-8464View further author information
ORCID Icon &
Xiaofeng Tanga Department of Blood Transfusion, Changzheng Hospital, Naval Medical University, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-0404-5746View further author information
ORCID Icon show all
Pages 365-370 | Published online: 10 May 2021

References

  • De Weers M, Tai YT, van der Veer MS, et al. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. J Immunol. 2011;186:1840–1848.
  • Albeniz I, Demir O, Turker-Sener L, et al. Erythrocyte CD38 as a prognostic marker in cancer. Hematology. 2007;12:409–414.
  • Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J. 1996;10:1408–1417.
  • Zocchi E, Franco L, Guida L, et al. A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem Biophys Res Commun. 1993;196:1459–1465.
  • Oostendorp M, van Bueren L, Doshi JJ, et al. When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy. Transfusion. 2015;55(6 Pt 2):1555–1562.
  • Quach H, Benson S, Haysom H, et al. Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma. Intern Med J. 2018;48:210–220.
  • Chapuy CI, Nicholson RT, Aguad MD, et al. Resolving the daratumumab interference with blood compatibility testing. Transfusion. 2015;55(6 Pt 2):1545–1554.
  • Chapuy CI, Aguad MD, Nicholson RT, et al. International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing. Transfusion. 2016;56(12):2964–2972.
  • Yeh TJ, Yeh CJ, Liu YC, et al. Manual Polybrene method for pretransfusion test could overcome the interference of daratumumab therapy in myeloma. Transfusion. 2019;59:2751–2752.
  • Berthelier V, Laboureau J, Boulla G, et al. Probing ligand-induced conformational changes of human CD38. Eur J Biochem. 2000;267(10):3056–3064.
  • Dizon MF. The challenges of daratumumab in transfusion medicine. Lab Med. 2017;48(1):6–9.
  • Selleng K, Gebicka PD, Thiele T. F(ab’)2 fragments to overcome daratumumab interference in transfusion tests. N Engl J Med. 2018;379(1):90–91.
  • Werle E, Ziebart J, Wasmund E, et al. Daratumumab interference in pretransfusion testing is overcome by addition of daratumumab Fab fragments to patients’ plasma. Transfus Med Hemother. 2019;46(6):423–430.
  • Lalezari P, Jiang AF. The manual Polybrene test: a simple and rapid procedure for detection of red cell antibodies. Transfusion. 1980;20:206–211.
  • Ferrer Z, Wright J, Moore BP, et al. Comparison of a modified manual hexadimethrine bromide (Polybrene) and a low-ionic-strength solution antibody detection technique. Transfusion. 1985;25:145–148.
  • Chu ML, Broadberry R. Experience with the manual Polybrene method in Taiwan. Transfusion. 1984;24:543.
  • Xin Y, Yannan F, Chunya M, et al. Three cases of crossmatch incompatibility caused by daratumumab. Chinese Journal of Blood Transfusion. 2020;33:529–531. In Chinese.
  • Fung MK, Eder A, Spitalnik SL, et al. AABB technical manual. 19th ed. Bethesda (MD): American Association of Blood Banks; 2017; method 3–18.
  • Lancman G, Arinsburg S, Jhang J, et al. Blood transfusion management for patients treated with anti-CD38 monoclonal antibodies. Front Immunol. 2018;9:2616.
  • Daniels G. Human blood groups. 3rd ed. Oxford: Wiley-Blackwell; 2013. p. 282–283.
  • Lingling W, Ying Y, Ziyan Z. Molecular characteristics of Kell blood group K positive in Chinese population and development and application of typing kits. J Clin Transfus Lab Med. 2008;10:110–113. In Chinese.
  • Klein HG, Anstee DJ. Immunology of red cells. Mollison’s blood transfusion in clinical medicine. 12th ed. London: Blackwell Science Ltd; 2013; p. 92.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.